COVID-19 mRNA Vaccines: Lessons Learned from the Registrational Trials and Global Vaccination Campaign
M. Nathaniel Mead • Stephanie Seneff • Russ Wolfinger • Jessica Rose •
Kris Denhaerynck • Steve Kirsch • Peter A. McCullough
Abstract
Our understanding of COVID-19 vaccinations and their impact on health and mortality has evolved substantially since the first vaccine rollouts. Published reports from the original randomized phase 3 trials concluded
that the COVID-19 mRNA vaccines could greatly reduce COVID-19 symptoms. In the interim, problems with the methods, execution, and reporting of these pivotal trials have emerged. Re-analysis of the Pfizer trial data
identified statistically significant increases in serious adverse events (SAEs) in the vaccine group. Numerous SAEs were identified following the Emergency Use Authorization (EUA), including death, cancer, cardiac
events, and various autoimmune, hematological, reproductive, and
neurological disorders. Furthermore, these products never underwent
adequate safety and toxicological testing in accordance with previously established scientific standards. Among the other major topics addressed
in this narrative review are the published analyses of serious harms to humans, quality control issues and process-related impurities, mechanisms underlying adverse events (AEs), the immunologic basis for vaccine inefficacy, and concerning mortality trends based on the registrational
trial data. The risk-benefit imbalance substantiated by the evidence to
date contraindicates further booster injections and suggests that, at a minimum, the mRNA injections should be removed from the childhood immunization program until proper safety and toxicological studies are conducted. Federal agency approval of the COVID-19 mRNA vaccines on a blanket-coverage population-wide basis had no support from an honest assessment of all relevant registrational data and commensurate
consideration of risks versus benefits. Given the extensive, well-
documented SAEs and unacceptably high harm-to-reward ratio, we urge governments to endorse a global moratorium on the modified mRNA products until all relevant questions pertaining to causality, residual DNA, and aberrant protein production are answered.
…
https://www.cureus.com/articles/203052-covid-19-mrna-vaccines-lessons-learned-from-the-registrational-trials-and-global-vaccination-campaign#!/
Онзи ще има ли достойнството да се появи и да се извини, най-вече на Радост
или пак ще се скрие като да не казвам какъв глутеус?
Предполагам че са странични ефекти от радиация и химия,
Стискайте палци.
Sysop: | Keyop |
---|---|
Location: | Huddersfield, West Yorkshire, UK |
Users: | 308 |
Nodes: | 16 (2 / 14) |
Uptime: | 91:25:13 |
Calls: | 6,923 |
Calls today: | 1 |
Files: | 12,382 |
Messages: | 5,434,024 |